StockGlow

XTL Biopharmaceuticals Ltd. (XTLB.TA)

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.

2.00+0.00%Healthcare
Compare XTLB.TA with
StockGlow Score
93
Bullish
BearishBullish
1 year ago+3821.6%

The outlook

XTL Biopharmaceuticals Ltd. currently reads as bullish based on above its 50- & 200-day averages, 91% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range91% of the way from its 52-week low to high
Market cap
$19.7M
52-wk high
2.20
52-wk low
0.02
50-day avg
1.88
200-day avg
0.52
Trailing P/E
—

Similar stocks

INCR.TAInterCure Ltd.$315.00+9.34%BLRX.TABioLineRx Ltd.$1.60+6.67%FRSX.TAForesight Autonomous Holdings Ltd.$4.40-2.22%CANF.TACan-Fite BioPharma Ltd.$519.00+5.15%ORMP.TAOramed Pharmaceuticals Inc.$1,350.00+8.78%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy